To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain

NCT04647773 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

687

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Peripheral Neuropathic Pain

Interventions

DRUG: HSK16149 20mg BID
DRUG: HSK16149 40mg BID
DRUG: HSK16149 60mg BID
DRUG: HSK16149 80mg BID
DRUG: Pregabalin 150mg BID
DRUG: Placebo BID

Sponsor

Haisco Pharmaceutical Group Co., Ltd.